(Q34307852)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Garry Cooper

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sara F Dunne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Brendon Dusel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Chi-Hao Luan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

D James Surmeier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Richard B Silverman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

1146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines

16 February 2020

cites work

1 reference

12 December 2020

Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis

1 reference

12 December 2020

Measurement of [Ca2+] using the Fluorometric Imaging Plate Reader (FLIPR).

1 reference

12 December 2020

Calcium antagonists: still appropriate as first line antihypertensive agents

1 reference

12 December 2020

Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis

1 reference

12 December 2020

L-type calcium channels and psychiatric disorders: A brief review

1 reference

12 December 2020

1,4-Dihydropyridines as calcium channel ligands and privileged structures

1 reference

12 December 2020

Use of antihypertensives and the risk of Parkinson disease

1 reference

12 December 2020

Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2.

1 reference

12 December 2020

Robust pacemaking in substantia nigra dopaminergic neurons

1 reference

12 December 2020

Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms

1 reference

12 December 2020

L-type calcium channels

1 reference

12 December 2020

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

1 reference

12 December 2020

L-type calcium channels: the low down

1 reference

12 December 2020

Parkinson's disease: clinical features and diagnosis

1 reference

12 December 2020

Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores

1 reference

12 December 2020

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

12 December 2020

L-type calcium channel blockers and Parkinson disease in Denmark

1 reference

12 December 2020

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.

1 reference

12 December 2020

Synthetic organic ligands active at voltage-gated calcium channels

1 reference

12 December 2020

International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels

1 reference

12 December 2020

Ueber künstliche Bildung des Harnstoffs

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNCOMMS2149

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NCOMMS2149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

16 February 2020

ADS bibcode

2012NatCo...3.1146K

0 references

1008672932

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093183%20AND%20SRC:MED&resulttype=core&format=json